Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 4/20 | 0.41 |
| ▸ | SRD5A1 | P18405 | 4/20 | 0.39 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.33 |
| ▸ | BRD2 | P25440 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31312201 | 0.78 | BRD4 (0.46) | BRD4SRD5A1SRD5A2BRD2 | |
| SCHEMBL26788780 | 0.76 | BRD4 (0.47) | BRD4SRD5A1SRD5A2BRD2 | |
| SCHEMBL23107033 | 0.76 | BRD4 (0.47) | BRD4SRD5A1SRD5A2BRD2 | |
| SCHEMBL21859839 | 0.76 | BRD4 (0.47) | BRD4SRD5A1SRD5A2BRD2 | |
| SCHEMBL31027444 | 0.74 | BRD4 (0.66) | BRD4SRD5A1SRD5A2BRD2 | |
| SCHEMBL21475939 | 0.73 | BRD4 (0.46) | BRD4SRD5A1SRD5A2BRD2 | |
| SCHEMBL31126694 | 0.72 | BRD4 (0.41) | BRD4BRD2 | |
| SCHEMBL19296766 | 0.71 | BRD4 (0.43) | BRD4SRD5A1SRD5A2BRD2 | |
| SCHEMBL27758738 | 0.71 | BRD4 (0.40) | BRD4SRD5A1SRD5A2BRD2 | |
| SCHEMBL27737854 | 0.71 | BRD4 (0.40) | BRD4SRD5A1SRD5A2BRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688738-A1 | HETEROCYCLOALKYL BETA-HYDROXY ALKYL AMINES FOR USE IN THE TREATMENT OF HYPERGLYCAEMIA AND DISORDERS CHARACTERISED BY HYPERGLYCAEMIA | Atrogi AB (SE) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024200736-A1 | HETEROCYCLOALKYL BETA-HYDROXY ALKYL AMINES FOR USE IN THE TREATMENT OF HYPERGLYCAEMIA AND DISORDERS CHARACTERISED BY HYPERGLYCAEMIA | ATROGI AB (SE) | 2024-10-03 | — | — | WO | disclosed |